Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (19)	1/15/1999 11:51:00 AM
From: Steve Lokness	Read Replies (1) \| Respond to of 360

I use to follow XOMA for a while but then didn't they move off shore or something? Can't remember but for some reason I lost interest. The market for those working on solving the bug resistance problem is huge IMO, and will do nothing but get bigger and bigger. I still follow MCDE, CBST and RBO. What really interest me is that I think someone is going to be able to come up with a DNA test for resistance strains of bacteria. I think that has the potential to be huge. IDBEF is working on a test, but management has made some poor decisions. Maybe one of the other players in the DNA test area will come out with something - VGIN, VYSI? Steve Push made an interesting statement on Yahoo about the potential - and I stress potential - market for their (GLGC) chip expression databases. It is worth reading as are all of his comments. Steve